A Senior Director at AstraZeneca takes us through how the company synthesises and validates novel PROTACs.

The pharma industry is embracing digitalisation of the lab. Recent advancements in paperless technology and AI offer a peek into what the smart labs of the future will look like.

By taking a more holistic approach to the design of mobile robots, cleanroom automation and aseptic production in the manufacture of pharmaceutical therapeutics could be made into a reality.

Data digitisation has led to a market shift in operability, as well as a strong emphasis on trust and a need for broad standardisation. Zisis Kozlakidis, Head of Laboratory Services and Biobanking at the International Agency for Research on Cancer, sat down with us to discuss current and future trends in digital data governance for healthcare, as well as the need for a coordinated data strategy going forward.

Helping unlock the promise of Cellular Therapies and Regenerative Medicines

3D CoSeedisTM from abc biopply ag is a novel scaffold-free 3D cell co-culture system.

Lantern will use their artificial intelligence (AI) platform, RADR, to accelerate the development of ADC candidates from discovery to clinical trials within a timeframe of approximately two years.

The organ modelling technology is making a splash in Roots Analysis market predictions, with recent waves of research grants and patents.

In Vitro Human Airway Model Systems

Organoids and 3D cell cultures are emerging as pivotal systems for understanding human organ development, modeling disease, screening for drug efficacy or toxicity, and personalized medicine.

Govinda Bhisetti, Principal Investigator and Head of Computational Chemistry at Biogen, leads a discussion group on what the revolutionary machine learning technology means for drug design.

Could integrating robots such as the CellQualia System into stem cell development pipelines be key to advancing these therapies?